Zobrazeno 1 - 10
of 24
pro vyhledávání: '"BED, biologically effective dose"'
Autor:
Maud le Guyader, Daniel Lam Cham Kee, Mathieu Gautier, Marie-Eve Chand-Fouche, Renaud Schiappa, Brice Thamphya, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 15-23 (2022)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Brachytherapy boost is a standard of care for locally advanced cervical cancer. • High-dose-rate brachytherapy (HDR-BT) boost procedure is not standardized. • The number of implants, fractions, doses and imaging differ in literatur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e241555be0dbedb8ff97b894cac2d8
https://doi.org/10.1016/j.ctro.2021.10.005
https://doi.org/10.1016/j.ctro.2021.10.005
Autor:
Christopher L. Hallemeier, Joleen M. Hubbard, Harigopal Sandhyavenu, A.E. Garda, William G. Breen, Karthik Gonuguntla, David M. Routman, Kenneth W. Merrell, Michael G. Haddock, Michelle A. Neben-Wittich, William S. Harmsen, Krishan R. Jethwa, Courtney N. Day, Thorvardur R. Halfdanarson
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 28, Iss, Pp 17-23 (2021)
Clinical and Translational Radiation Oncology, Vol 28, Iss, Pp 17-23 (2021)
Highlights • IMRT is associated with favorable toxicity rates for patients with anal cancer. • Outcomes were favorable for those with T3-4 tumors or lymph node involvement. • Current smokers are at a higher risk of severe dermatologic toxicity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907995308fcc27495fb8228022a7d1e2
https://doi.org/10.1016/j.ctro.2021.02.002
https://doi.org/10.1016/j.ctro.2021.02.002
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Elsevier, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 44-48 (2020)
Clinical and Translational Radiation Oncology, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Elsevier, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 44-48 (2020)
Clinical and Translational Radiation Oncology, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Highlights • No correlation between radiotherapy and the development of MS is to date described. • Demyelination can occur after radiotherapy in tissue adjacent to irradiated tumours. • MS lesions seem to occur in regions irradiated with a mean
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab7c3355ef86e95b8fb1ce580a17141
https://doi.org/10.1016/j.ctro.2020.01.001
https://doi.org/10.1016/j.ctro.2020.01.001
Autor:
Longhua Chen, Liji Cao, Bing Yang, Amir Abdollahi, Stephan Brons, Mahmoud Moustafa, Juergen Debus, Christian Schwager, Cheng Zhou, Ming Chen, Ying Dai, Oliver Jaekel, Bleddyn Jones
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 14, Iss, Pp 25-32 (2019)
Clinical and Translational Radiation Oncology, Vol 14, Iss, Pp 25-32 (2019)
Highlights • Determining normal tissue tolerance of organs at risk is of utmost importance for the success of carbon ion radiotherapy (CIRT). • This manuscript is the first report on experimental RBE for development of lung fibrosis assessed by q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54684f88bb01f0819d99568e0ee17041
https://doi.org/10.1016/j.ctro.2018.10.005
https://doi.org/10.1016/j.ctro.2018.10.005
Autor:
E. Gelb, T. Jonathan Yang, Andreas Rimner, David Barron, Abraham J. Wu, Weiji Shi, Ellen Yorke, Zhigang Zhang, Daphna Y. Gelblum, Natalie A. Lockney
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 7, Iss, Pp 91-93 (2017)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • An examination of mutations in PIK3CA signaling pathways and radioresistance. • PIK3CA mutation was found to be associated with local failure after lung SBRT. • This is a small study and there is need for further validation.
O
O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a4075d1e830fad9102f54a74ca8435
http://www.sciencedirect.com/science/article/pii/S2405630817300812
http://www.sciencedirect.com/science/article/pii/S2405630817300812
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohamed Faouzi, Nicolas Reyns, Henri-Arthur Leroy, Iulia Peciu-Florianu, Maximilien Vermandel, Constantin Tuleasca
Publikováno v:
Journal of neurosurgery, vol. 134, pp. 1901–1911
OBJECTIVE Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05ea04cf963552cc08f95596c9ea825
https://infoscience.epfl.ch/record/286654
https://infoscience.epfl.ch/record/286654
Autor:
Hardcastle N; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia., Gaudreault M; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Yeo AU; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Ungureanu E; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Markham C; Department of Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Barnes R; Department of Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Chander S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Chu J; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Publikováno v:
Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2023 Jan 04; Vol. 25, pp. 100407. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2023).
Autor:
le Guyader M; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Lam Cham Kee D; Department of Radiation Oncology, Pôle Santé République, Clermont-Ferrand, France., Thamphya B; Department of Statistics, Antoine Lacassagne Cancer Center, University of Côte d'Azur, Nice, France., Schiappa R; Department of Statistics, Antoine Lacassagne Cancer Center, University of Côte d'Azur, Nice, France., Gautier M; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Chand-Fouche ME; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France., Hannoun-Levi JM; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Côte d'Azur, 33 avenue Valombrose, 06189 Nice Cedex 2, Nice, France.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2021 Nov 06; Vol. 32, pp. 15-23. Date of Electronic Publication: 2021 Nov 06 (Print Publication: 2022).